No Data
FSD Pharma Updates Shareholders on Recent Changes
Sector Update: Health Care Stocks Decline in Late Afternoon Trading
Health care stocks were retreating late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.4%. The iShares Biotechnology ETF (IBB)
FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
FSD Pharma's (HUGE) former board chairman and chief executive owes more than $2.2 million, plus interest, to the company, after a federal court confirmed a November 2022 arbitration award. Former FSD
FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization
FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Week of 6/2/24
FSD Pharma Clinches $3M Victory in Arbitration